US FDA approves orphan drug MYALEPTâ„¢ (metreleptin for injection)

US FDA approves orphan drug MYALEPTâ„¢ (metreleptin for injection)

[at noodls] – AstraZeneca today announced the US Food and Drug Administration (FDA) approved orphan drug MYALEPTâ„¢ (metreleptin for injection), which is indicated as an adjunct to diet as replacement therapy for the … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view

Share this post